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Abstract
Background:  Germ cell tumours are uncommon in aged man. We present a rare case of
metastatic seminoma of the testis associated with liver and renal insufficiencies in a 78-years-old
man managed successfully with carboplatin based chemotherapy.
Case presentation: A 78 years old man admitted with signs and symptoms suggestive of a
testicular cancer with alteration of health. Computed tomography of the pelvis and abdomen
showed a large retroperitoneal tumour. The diagnosis of seminoma was established from the
histological study of the left orchidectomy. At admission, the liver and renal check-up showed liver
and renal insufficiencies.
Conclusion:  The patient received 4 of carboplatin based chemotherapy with significant
improvement in symptoms, and complete radiological response.
Background
Germ cell tumour is the most common solid tumour in
the young adult man but this disease is rare in aged
man[1,2]. Pure seminoma is the most common form of
testicular germ cell tumour. In this note we present a case
of metastatic seminoma of the testis, associated with renal
and liver insufficiency's which was managed successfully
with carboplatin based chemotherapy.
Case presentation
A 78 years old man was admitted to our hospital with 4
years history of swollen left testicle. This man suffered
from pain in scrotum and abdomen with alteration of
health. The performance status at admission was equal to
3 (PS = 3). A physical examination revealed a fixed
abdominal mass. The Computed tomography scan of the
pelvis, abdomen and lung showed a large retroperitoneal
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tumour, measuring 18 × 16 cm (Figure 1). The diagnosis
of pure seminoma was established from the histological
study of the left orchidectomy. The serum markers results
showed: AFP (alpha-fetoprotein) = 1,7 ng/ml (normal); β
HCG (Human chorionic gonadotropin) = 515 U/L
(increased) and LDH (Lactate dehydrogenase) = 3345 U/
L (increased). The seminoma was at stage IIC according to
the 2002 TNM classification for genitourinary tumours
and of good prognosis according to the International
Germ Cell Consensus Classification. A complete blood
count (red blood cell, white blood cells and platelet) was
normal. The estimated creatinine clearance showed renal
insufficiency (40 mml/min). The liver check-up showed
liver insufficiency with serum transaminase increased up
to 2 fold for ALAT and up to 3 fold for ASAT and with GGT
(Gamma Glutamyl Transferase) increased up to 2 fold. In
addition, the prothrombin rate decreased to 19%. The
bilirubinemia was normal. Liver metastasis was the first
hypothesis of liver insufficiency considered but the CT
scan and ultrasound imaging did not shows liver metasta-
sis. The second hypothesis was the presence of liver infec-
tion by B or C virus. This hypothesis was disregarded by
the fact that B antibody was positive while HBs antigen
was negative. After hydration, corticotherapy and treat-
ment by vitamin K and the increase of PT up to 50% the
patient received 2 cycles of chemotherapy with single
agent carboplatin AUC 7 with good tolerance of treat-
ment. After the treatment the patient health was drasti-
cally improved with normalisation of serum transaminase
and prothrombin rate (100%). Then, the patient received
2 other cycles of carboplatin AUC 5 and etoposide (100
mg/m2 at days 1 to 5). After the treatment completed the
Computed tomography scan of the abdomen showed the retroperitoneal tumour Figure 1
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symptoms disappeared (PS = 0 and the abdomen mass
shrunk), the serum markers returned to normal, with
complete response of the retroperitoneal tumour in CT
scan. The patient is still alive without disease, 5 months
after the end of chemotherapy.
Discussion
Germ cell tumour is the most common solid tumour in
the man aged between 15 and 34 years but this disease is
uncommon in aged man. Less than 4% of patients with
germ cell tumors are aged 65 years or older [1,2]. Pure
seminoma is the most common form of testicular germ
cell tumour, representing 40–50% of all germ cell
tumours. In the elderly patients, 82% of the germ cell
tumours were seminomas [3]. The cure rate of germ cell
tumour is comprised between 90 to 95%[1]. This success
in treatment is the result of multimodality therapy includ-
ing surgery, radiotherapy and especially cisplatin based
chemotherapy [1,4]. Cisplatin is highly effective in com-
bination with other drugs, but universally associated with
emesis, neurotoxicity, and renal toxicity. For good-risk
patients, etoposide and cisplatin (EP) for four cycles or
bleomycin, etoposide, and cisplatin (BEP) for three cycles
are the regimens of choice with a durable response rate in
excess of 90%[5,6]. Carboplatin, although more myelo-
toxic does not cause these problems. Initial study sug-
gested a high efficacy for this drug, particularly in
seminoma [7,8]. Two series from the Royal Marsden Hos-
pital and Germany evaluated single agent carboplatin in
metastatic seminoma. The results from these two studies
were remarkably similar, with disease free survival rates of
71% and 77% and survival rates of 91% and 93%, respec-
tively. The medical research council (MRC) randomised
130 patients with metastatic seminoma between carbopl-
atin and cisplatin plus etoposide. Carboplatin was associ-
ated with 10% inferior progression-free survival (71 vs
81%) with a non significant survival difference favouring
the cisplatin combination (84% vs 89%) [9]. In a multi-
institutional study Bajorin et al compared cisplatin and
etoposide against carboplatin and etoposide. Twenty-two
percent of randomised patients had seminoma. The study
showed equivalent response rates and survival but inferior
event free survival for carboplatin group [10]. Our elderly
patient who developed severe alteration of health, liver
and renal insufficiency's, was treated by 2 cycles of carbo-
platin single agent carboplatin AUC 7 and 2 cycles of car-
boplatin AUC 5 and etoposide (500 m/m2) with
significant improvement in symptoms complete response
of the retroperitoneal tumour.
Conclusion
1. The seminoma can arise in the men above the age of 70.
2. Carboplatin in monotherapy or in combination with
etoposide can be used to treat elderly patients.
3. Single agent carboplatin AUC 7 can be used to treat
advanced seminoma in elderly patients with severe altera-
tion of health, renal and liver insufficiencies.
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